FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients.

2.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

3.

BTK Inhibitor Active in Half of Patients With Richter Transformation

4.

Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia

5.

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot